Neuropsychological testing and assessment for dementia

Alzheimer's and Dementia

Volumn 3, Issue 4, 2007, Pages 299-317

  Jacova, Claudia ^a   Kertesz, Andrew ^b   Blair, Mervin ^b   Fisk, John D ^c   Feldman, Howard H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Brief cognitive tests; Cognitive impairment, no dementia (CIND); Dementia diagnosis; Dementia differential diagnosis; Mild cognitive impairment (MCI); Neuropsychological testing; Screening tests

Indexed keywords

ALZHEIMER DISEASE; ANAMNESIS; COGNITION; COGNITIVE DEFECT; COGNITIVE REHABILITATION; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HUMAN; INTERVIEW; MEDICAL DECISION MAKING; MEMORY CONSOLIDATION; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; REVIEW; RISK ASSESSMENT; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

EID: 35148883105     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2007.07.011     Document Type: Review

References (160)

1. The Houston conference on specialty education and training in clinical neuropsychology. Policy statement. Archives of Clinical Neuropsychology 1998;157-250.
2. Mulherin S.A., and Miller W.C. Spectrum bias or spectrum effect? subgroup variation in diagnostic test evaluation. Ann Intern Med 137 (2002) 598-602
3. Lorentz W.J., Scanlan J.M., and Borson S. Brief screening tests for dementia. Can J Psychiatry 47 (2002) 723-733
4. Folstein M.F., Robins L.N., and Helzer J.E. The Mini-Mental State Examination. Arch Gen Psychiatry 40 (1983) 812
5. Tombaugh T.N., and McIntyre N.J. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40 (1992) 922-935
6. Tombaugh T.N., McDowell I., Kristjansson B., and Hubley A.M. Mini-Mental State Examination (MMSE) and the modified MMSE (3MS): a psychometric comparison and normative data. Psychol Assess 8 (1996) 48-59
7. Lindsay J., Laurin D., Verreault R., Hebert R., Helliwell B., Hill G.B., et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 156 (2002) 445-453
8. Kraemer H.C., Moritz D.J., and Yesavage J. Adjusting Mini-Mental State Examination scores for age and educational level to screen for dementia: correcting bias or reducing validity?. Int Psychogeriatr 10 (1998) 43-51
9. Feldman H.H., and Jacova C. Mild cognitive impairment. Am J Geriatr Psychiatry 13 (2005) 645-655
10. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., and Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56 (1999) 303-308
11. Graham J.E., Rockwood K., Beattie B.L., Eastwood R., Gauthier S., Tuokko H., et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet 349 (1997) 1793-1796
12. Fisk J.D., Merry H.R., and Rockwood K. Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology 61 (2003) 1179-1184
13. Feldman H., Levy A.R., Hsiung G.Y., Peters K.R., Donald A., Black S.E., et al. A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results. Neuroepidemiology 22 (2003) 265-274
14. Petersen R.C., Stevens J.C., Ganguli M., Tangalos E.G., Cummings J.L., and DeKosky S.T. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review)-report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56 (2001) 1133-1142
15. Nasreddine Z.S., Phillips N.A., Bedirian V., Charbonneau S., Whitehead V., Collin I., et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53 (2005) 695-699
16. Kalbe E., Kessler J., Calabrese P., Smith R., Passmore A.P., Brand M., et al. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry 19 (2004) 136-143
17. Loewenstein D.A., Barker W.W., Harwood D.G., Luis C., Acevedo A., Rodriguez I., et al. Utility of a modified Mini-Mental State Examination with extended delayed recall in screening for mild cognitive impairment and dementia among community dwelling elders. Int J Geriatr Psychiatry 15 (2000) 434-440
18. Tang-Wai D.F., Knopman D.S., Geda Y.E., Edland S.D., Smith G.E., Ivnik R.J., et al. Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment. Arch Neurol 60 (2003) 1777-1781
19. Eibenstein A., Fioretti A.B., Simaskou M.N., Sucapane P., Mearelli S., Mina C., et al. Olfactory screening test in mild cognitive impairment. Neurol Sci 26 (2005) 156-160
20. Doty R.L., Reyes P.F., and Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull 18 (1987) 597-600
21. Morgan C.D., and Murphy C. Olfactory event-related potentials in Alzheimer's disease. J Int Neuropsychol Soc 8 (2002) 753-763
22. Teng E.L., and Chui H.C. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry 48 (1987) 314-318
23. McDowell I., Hill G., Lindsay J., Helliwell B., Costa L., Beattie B.L., et al. Canadian Study of Health and Aging: study methods and prevalence of dementia. CMAJ 150 (1994) 899-913
24. Tuokko H., Hadjistavropoulos T., Miller J.A., and Beattie B.L. The Clock Test: a sensitive measure to differentiate normal elderly from those with Alzheimer disease. J Am Geriatr Soc 40 (1992) 579-584
25. Bush C., Kozak J., and Elmslie T. Screening for cognitive impairment in the elderly. Can Fam Physician 43 (1997) 1763-1768
26. Shulman K.I. Clock-drawing: is it the ideal cognitive screening test?. Int J Geriatr Psychiatry 15 (2000) 548-561
27. Morris J.C. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr 9 Suppl 1 (1997) 173-176
28. Powlishta K.K., Von Dras D.D., Stanford A., Carr D.B., Tsering C., Miller J.P., et al. The clock drawing test is a poor screen for very mild dementia. Neurology 59 (2002) 898-903
29. De Lepeleire J., Heyman J., Baro F., and Buntinx F. A combination of tests for the diagnosis of dementia had a significant diagnostic value. J Clin Epidemiol 58 (2005) 217-225
30. Stahelin H.B., Monsch A.U., and Spiegel R. Early diagnosis of dementia via a two-step screening and diagnostic procedure. Int Psychogeriatr 9 Suppl 1 (1997) 123-130
31. Solomon P.R., Hirschoff A., Kelly B., Relin M., Brush M., DeVeaux R.D., et al. A 7 minute neurocognitive screening battery highly sensitive to Alzheimer's disease. Arch Neurol 55 (1998) 349-355
32. Solomon P.R., Brush M., Calvo V., Adams F., DeVeaux R.D., Pendlebury W.W., et al. Identifying dementia in the primary care practice. Int Psychogeriatr 12 (2000) 483-493
33. Kuslansky G., Buschke H., Katz M., Sliwinski M., and Lipton R.B. Screening for Alzheimer's disease: the memory impairment screen versus the conventional three-word memory test. J Am Geriatr Soc 50 (2002) 1086-1091
34. Brodaty H., Pond D., Kemp N.M., Luscombe G., Harding L., Berman K., et al. The GPCOG: A new screening test for dementia designed for general practice. J Am Geriatr Soc 50 (2002) 530-534
35. Kilada S., Gamaldo A., Grant E.A., Moghekar A., Morris J.C., and O'Brien R.J. Brief screening tests for the diagnosis of dementia: comparison with the mini-mental state exam. Alzheimer Dis Assoc Disord 19 (2005) 8-16
36. Storey J.E., Rowland J.T., Basic D., Conforti D.A., and Dickson H.G. The Rowland Universal Dementia Assessment Scale (RUDAS): a multicultural cognitive assessment scale. Int Psychogeriatr 16 (2004) 13-31
37. Darvesh S., Leach L., Black S.E., Kaplan E., and Freedman M. The behavioural neurology assessment. Can J Neurol Sci 32 (2005) 167-177
38. Stuss D.T., Meiran N., Guzman D.A., Lafleche G., and Willmer J. Do long tests yield a more accurate diagnosis of dementia than short tests? a comparison of 5 neuropsychological tests. Arch Neurol 53 (1996) 1033-1039
39. Chui H., and Zhang Q. Evaluation of dementia: a systematic study of the usefulness of the American Academy of Neurology's practice parameters. Neurology 49 (1997) 925-935
40. Chertkow H., Bergman H., Schipper H.M., Gauthier S., Bouchard R., Fontaine S., et al. Assessment of suspected dementia. Can J Neurol Sci 28 Suppl 1 (2001) 28-41
41. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
42. Levy R. Aging-associated cognitive decline: Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr 6 (1994) 63-68
43. Peters K.R., Graf P., Hayden S., and Feldman H. Neuropsychological characterization of cognitively-impaired-not-demented (CIND) individuals: clinical comparison data. Clin Neuropsychol 18 (2004) 208-228
44. Peters K.R., Graf P., Hayden S., and Feldman H. Neuropsychological subgroups of cognitively-impaired-not-demented (CIND) individuals: delineation, reliability, and predictive validity. J Clin Exp Neuropsychol 27 (2005) 164-188
45. Lopez O.L., Becker J.T., Jagust W.J., Fitzpatrick A., Carlson M.C., DeKosky S.T., et al. Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry 77 (2006) 159-165
46. Grundman M., Petersen R.C., Ferris S.H., Thomas R.G., Aisen P.S., Bennett D.A., et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol 61 (2004) 59-66
47. Kramer J.H., Nelson A., Johnson J.K., Yaffe K., Glenn S., Rosen H.J., et al. Multiple cognitive deficits in amnestic mild cognitive impairment. Dement Geriatr Cogn Disord 22 (2006) 306-311
48. Collie A., Maruff P., and Currie J. Behavioral characterization of mild cognitive impairment. J Clin Exp Neuropsychol 24 (2002) 720-733
49. Welsh K., Butters N., Hughes J., Mohs R., and Heyman A. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol 48 (1991) 278-281
50. Cahn D.A., Salmon D.P., Butters N., Wiederholt W.C., Corey-Bloom J., Edelstein S.L., et al. Detection of dementia of the Alzheimer type in a population-based sample: neuropsychological test performance. J Int Neuropsychol Soc 1 (1995) 252-260
51. Swearer J.M., O'Donnell B.F., Kane K.J., Hoople N.E., and Lavoie M. Delayed recall in dementia: sensitivity and specificity in patients with higher than average general intellectual abilities. Neuropsychiatry Neuropsychol Behav Neurol 11 (1998) 200-206
52. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition, text revision (DSM-IV-TR) (2000), American Psychiatric Association, Arlington, VA
53. Steenhuis R.E., and Ostbye T. Neuropsychological test performance of specific diagnostic groups in the Canadian Study of Health and Aging (CSHA). J Clin Exp Neuropsychol 17 (1995) 773-785
54. Lambon Ralph M.A., Patterson K., Graham N., Dawson K., and Hodges J.R. Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases. Brain 126 Pt 11 (2003) 2350-2362
55. Small B.J., Fratiglioni L., Viitanen M., Winblad B., and Backman L. The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol 57 (2000) 839-844
56. Hall C.B., Lipton R.B., Sliwinski M., and Stewart W.F. A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease. Stat Med 19 (2000) 1555-1566
57. Rubin E.H., Storandt M., Miller J.P., Kinscherf D.A., Grant E.A., Morris J.C., et al. A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Arch Neurol 55 (1998) 395-401
58. Amieva H., Jacqmin-Gadda H., Orgogozo J.M., Carret N., Helmer C., Letenneur L., et al. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain 128 Pt 5 (2005) 1093-1101
59. Chen P., Ratcliff G., Belle S.H., Cauley J.A., DeKosky S.T., and Ganguli M. Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry 58 (2001) 853-858
60. Maruff P., Collie A., Darby D., Weaver-Cargin J., Masters C., and Currie J. Subtle memory decline over 12 months in mild cognitive impairment. Dement Geriatr Cogn Disord 18 (2004) 342-348
61. Fowler K.S., Saling M.M., Conway E.L., Semple J.M., and Louis W.J. Paired associate performance in the early detection of DAT. J Int Neuropsychol Soc 8 (2002) 58-71
62. Bowen J., Teri L., Kukull W., McCormick W., McCurry S.M., and Larson E.B. Progression to dementia in patients with isolated memory loss. Lancet 349 (1997) 763-765
63. Tierney M.C., Yao C., Kiss A., and McDowell I. Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology 64 (2005) 1853-1859
64. Tierney M.C., Szalai J.P., Snow W.G., Fisher R.H., Nores A., Nadon G., et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology 46 (1996) 661-665
65. Arnaiz E., Almkvist O., Ivnik R.J., Tangalos E.G., Wahlund L.O., Winblad B., et al. Mild cognitive impairment: a cross-national comparison. J Neurol Neurosurg Psychiatry 75 (2004) 1275-1280
66. Artero S., and Ritchie K. The detection of mild cognitive impairment in the general practice setting. Aging Ment Health 7 (2003) 251-258
67. Elias M.F., Beiser A., Wolf P.A., Au R., White R.F., and D'Agostino R.B. The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham Cohort. Arch Neurol 57 (2000) 808-813
68. Howieson D.B., Dame A., Camicioli R., Sexton G., Payami H., and Kaye J.A. Cognitive markers preceding Alzheimer's dementia in the healthy oldest old. J Am Geriatr Soc 45 (1997) 584-589
69. Blackwell A.D., Sahakian B.J., Vesey R., Semple J.M., Robbins T.W., and Hodges J.R. Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease. Dement Geriatr Cogn Disord 17 (2004) 42-48
70. Palmer K., Backman L., Winblad B., and Fratiglioni L. Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study. BMJ 326 (2003) 245
71. Devanand D.P., Folz M., Gorlyn M., Moeller J.R., and Stern Y. Questionable dementia: clinical course and predictors of outcome. J Am Geriatr Soc 45 (1997) 321-328
72. Bozoki A., Giordani B., Heidebrink J.L., Berent S., and Foster N.L. Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch Neurol 58 (2001) 411-416
73. Backman L., Jones S., Berger A.K., Laukka E.J., and Small B.J. Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology 19 (2005) 520-531
74. Herlitz A., Small B.J., Fratiglioni L., Almkvist O., Viitanen M., and Backman L. Detection of mild dementia in community surveys: is it possible to increase the accuracy of our diagnostic instruments?. Arch Neurol 54 (1997) 319-324
75. Tian J., Bucks R.S., Haworth J., and Wilcock G. Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful. J Neurol Neurosurg Psychiatry 74 (2003) 433-438
76. Fabrigoule C., Rouch I., Taberly A., Letenneur L., Commenges D., Mazaux J.M., et al. Cognitive process in preclinical phase of dementia. Brain 121 Pt 1 (1998) 135-141
77. Ritchie K., Leibovici D., Ledesert B., and Touchon J. A typology of sub-clinical senescent cognitive disorder. Br J Psychiatry 168 (1996) 470-476
78. Ivnik R.J., Smith G.E., Cerhan J.H., Boeve B.F., Tangalos E.G., and Petersen R.C. Understanding the diagnostic capabilities of cognitive tests. Clin Neuropsychol 15 (2001) 114-124
79. Neary D., Snowden J., and Mann D. Frontotemporal dementia. Lancet Neurol 4 (2005) 771-780
80. Feldman H., and Kertesz A. Diagnosis, classification and natural history of degenerative dementias. Can J Neurol Sci 28 Suppl 1 (2001) S17-S27
81. Gustafson L. Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 6 (1987) 209-223
82. Neary D., Snowden J.S., Northen B., and Goulding P. Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry 51 (1988) 353-361
83. Aarsland D., Litvan I., Salmon D., Galasko D., Wentzel-Larsen T., and Larsen J.P. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry 74 (2003) 1215-1220
84. Ballard C.G., Ayre G., O'Brien J., Sahgal A., McKeith I.G., Ince P.G., et al. Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 10 (1999) 104-108
85. Calderon J., Perry R.J., Erzinclioglu S.W., Berrios G.E., Dening T.R., and Hodges J.R. Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease. J Neurol Neurosurg Psychiatry 70 (2001) 157-164
86. Litvan I., Mohr E., Williams J., Gomez C., and Chase T.N. Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease. J Neurol Neurosurg Psychiatry 54 (1991) 25-29
87. Looi J.C., and Sachdev P.S. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology 53 (1999) 670-678
88. Corkin S. Some relationships between global amnesia and the memory impairment in Alzheimer's disease. In: Corkin S., Davis K., and Growdon J.H. (Eds). Alzheimer's disease: a report of progress on research (1982), Raven Press, New York 149-164
89. Karlsson T., Backman L., Herlitz A., Nilsson L.G., Winblad B., and Osterlind P.O. Memory improvement at different stages of Alzheimer's disease. Neuropsychologia 27 (1989) 737-742
90. Martin A., Brouwers P., Cox C., and Fedio P. On the nature of the verbal memory deficit in Alzheimer's disease. Brain Lang 25 (1985) 323-341
91. Hodges J.R. Frontotemporal dementia (Pick's disease): clinical features and assessment. Neurology 56 Suppl 4 (2001) 6-10
92. Pasquier F., Grymonprez L., Lebert F., and Van der Linden M. Memory impairment differs in frontotemporal dementia and Alzheimer's disease. Neurocase 7 (2001) 161-171
93. Collerton D., Burn D., McKeith I., and O'Brien J. Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. Dement Geriatr Cogn Disord 16 (2003) 229-237
94. Doubleday E.K., Snowden J.S., Varma A.R., and Neary D. Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry 72 (2002) 602-607
95. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol 2 (2003) 229-237
96. Ballard C.G., Aarsland D., McKeith I., O'Brien J., Gray A., Cormack F., et al. Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology 59 (2002) 1714-1720
97. Mendez M.F., and Cummings J.L. Dementia: a clinical approach, 3 ed (2003), Butterworth-Heinemann (Elsevier), Philadelphia
98. Hamilton J.M., Salmon D.P., Galasko D., Delis D.C., Hansen L.A., Masliah E., et al. A comparison of episodic memory deficits in neuropathologically-confirmed dementia with Lewy bodies and Alzheimer's disease. J Int Neuropsychol Soc 10 (2004) 689-697
99. Helkala EL, Laulumaa V, Soininen H, Riekkinen PJ. Recall and recognition memory in patients with Alzheimer's and Parkinson's diseases. Ann Neurol;24:214-7.
100. Pillon B., Deweer B., Agid Y., and Dubois B. Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases. Arch Neurol 50 (1993) 374-379
101. Tierney M.C., Black S.E., Szalai J.P., Snow W.G., Fisher R.H., Nadon G., et al. Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia. Arch Neurol 58 (2001) 1654-1659
102. Branconnier R.J., Cole J.O., Spera K.F., and DeVitt D.R. Recall and recognition as diagnostic indices of malignant memory loss in senile dementia: a Bayesian analysis. Exp Aging Res 8 (1982) 189-193
103. Davis P.E., and Mumford S.J. Cued recall and the nature of the memory disorder in dementia. Br J Psychiatry 144 (1984) 383-386
104. Chen P., Ratcliff G., Belle S.H., Cauley J.A., DeKosky S.T., and Ganguli M. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology 55 (2000) 1847-1853
105. Grossman M. Frontotemporal dementia: a review. J Int Neuropsychol Soc 8 (2002) 566-583
106. Kertesz A., Davidson W., McCabe P., and Munoz D. Behavioral quantitation is more sensitive than cognitive testing in frontotemporal dementia. Alzheimer Dis Assoc Disord 17 (2003) 223-229
107. Faber-Langendoen K., Morris J.C., Knesevich J.W., LaBarge E., Miller J.P., and Berg L. Aphasia in senile dementia of the Alzheimer type. Ann Neurol 23 (1988) 365-370
108. Kertesz A., Appell J., and Fisman M. The dissolution of language in Alzheimer's disease. Can J Neurol Sci 13 Suppl (1986) 415-418
109. Appell J., Kertesz A., and Fisman M. A study of language functioning in Alzheimer patients. Brain Lang 17 (1982) 73-91
110. Cummings J.L., Darkins A., Mendez M., Hill M.A., and Benson D.F. Alzheimer's disease and Parkinson's disease: comparison of speech and language alterations. Neurology 38 (1988) 680-684
111. Huber S.J., Shuttleworth E.C., and Freidenberg D.L. Neuropsychological differences between the dementias of Alzheimer's and Parkinson's diseases. Arch Neurol 46 (1989) 1287-1291
112. Grossman M., Carvell S., Gollomp S., Stern M.B., Vernon G., and Hurtig H.I. Sentence comprehension and praxis deficits in Parkinson's disease. Neurology 41 (1991) 1620-1626
113. Grossman M., Carvell S., Stern M.B., Gollomp S., and Hurtig H.I. Sentence comprehension in Parkinson's disease: the role of attention and memory. Brain Lang 42 (1992) 347-384
114. Howard D., and Patterson K. Pyramids and palm trees: a test of semantic access from pictures and words (1992), Thames Valley Test Company, St Edmunds, Suffolk, UK
115. Shimomura T., Mori E., Yamashita H., Imamura T., Hirono N., Hashimoto M., et al. Cognitive loss in dementia with Lewy bodies and Alzheimer disease. Arch Neurol 55 (1998) 1547-1552
116. Cormack F., Aarsland D., Ballard C., and Tovee M.J. Pentagon drawing and neuropsychological performance in dementia with Lewy bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia. Int J Geriatr Psychiatry 19 (2004) 371-377
117. Stern Y., Richards M., Sano M., and Mayeux R. Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease. Arch Neurol 50 (1993) 1040-1045
118. Stern Y., Mayeux R., Rosen J., and Ilson J. Perceptual motor dysfunction in Parkinson's disease: a deficit in sequential and predictive voluntary movement. J Neurol Neurosurg Psychiatry 46 (1983) 145-151
119. Rascovsky K., Salmon D.P., Ho G.J., Galasko D., Peavy G.M., Hansen L.A., et al. Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD. Neurology 58 (2002) 1801-1808
120. Bathgate D., Snowden J.S., Varma A., Blackshaw A., and Neary D. Behaviour in frontotemporal dementia, Alzheimer's disease and vascular dementia. Acta Neurol Scand 103 (2001) 367-378
121. Bozeat S., Gregory C.A., Ralph M.A., and Hodges J.R. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease?. J Neurol Neurosurg Psychiatry 69 (2000) 178-186
122. Kertesz A., Davidson W., and Fox H. Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci 24 (1997) 29-36
123. Kertesz A., Nadkarni N., Davidson W., and Thomas A.W. The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc 6 (2000) 460-468
124. Levy M.L., Miller B.L., Cummings J.L., Fairbanks L.A., and Craig A. Alzheimer disease and frontotemporal dementias: behavioral distinctions. Arch Neurol 53 (1996) 687-690
125. Miller B.L., Ikonte C., Ponton M., Levy M., Boone K., Darby A., et al. A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations. Neurology 48 (1997) 937-942
126. Davies R.R., Hodges J.R., Kril J.J., Patterson K., Halliday G.M., and Xuereb J.H. The pathological basis of semantic dementia. Brain 128 Pt 9 (2005) 1984-1995
127. Marczinski C.A., Davidson W., and Kertesz A. A longitudinal study of behavior in frontotemporal dementia and primary progressive aphasia. Cogn Behav Neurol 17 (2004) 185-190
128. Devanand D.P. The interrelations between psychosis, behavioral disturbance, and depression in Alzheimer disease. Alzheimer Dis Assoc Disord 13 Suppl 2 (1999) S3-S8
129. Mendez M.F., Martin R.J., Smyth K.A., and Whitehouse P.J. Psychiatric symptoms associated with Alzheimer's disease. J Neuropsychiatry Clin Neurosci 2 (1990) 28-33
130. Paulsen J.S., Salmon D.P., Thal L.J., Romero R., Weisstein-Jenkins C., Galasko D., et al. Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology 54 (2000) 1965-1971
131. Ballard C., Holmes C., McKeith I., Neill D., O'Brien J., Cairns N., et al. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. Am J Psychiatry 156 (1999) 1039-1045
132. Aarsland D., Ballard C., Larsen J.P., and McKeith I. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. Int J Geriatr Psychiatry 16 (2001) 528-536
133. Aarsland D., Cummings J.L., and Larsen J.P. Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease. Int J Geriatr Psychiatry 16 (2001) 184-191
134. Fenelon G., Mahieux F., Huon R., and Ziegler M. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 123 Pt 4 (2000) 733-745
135. Ballard C., Neill D., O'Brien J., McKeith I.G., Ince P., and Perry R. Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J Affect Disord 59 (2000) 97-106
136. Cummings J.L., Miller B., Hill M.A., and Neshkes R. Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type. Arch Neurol 44 (1987) 389-393
137. Starkstein S.E., Sabe L., Vazquez S., Teson A., Petracca G., Chemerinski E., et al. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease. Stroke 27 (1996) 408-414
138. Sultzer D.L., Levin H.S., Mahler M.E., High W.M., and Cummings J.L. A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease. Am J Psychiatry 150 (1993) 1806-1812
139. Srikanth S., Nagaraja A.V., and Ratnavalli E. Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia. J Neurol Sci 236 (2005) 43-48
140. Rao R., and Howard R. Vascular dementia: dead or alive?. Int J Geriatr Psychiatry 13 (1998) 277-284
141. Freedman M., Leach L., Kaplan E., and Shulman K.I. Clock drawing. a neuropsychological analysis (1994), Oxford University Press, New York
142. Cahn-Weiner D.A., Williams K., Grace J., Tremont G., Westervelt H., and Stern R.A. Discrimination of dementia with Lewy bodies from Alzheimer disease and Parkinson disease using the clock drawing test. Cogn Behav Neurol 16 (2003) 85-92
143. Rouleau I., Salmon D.P., Butters N., Kennedy C., and McGuire K. Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease. Brain Cogn 18 (1992) 70-87
144. Rouleau I., Salmon D.P., and Butters N. Longitudinal analysis of clock drawing in Alzheimer's disease patients. Brain Cogn 31 (1996) 17-34
145. Gregory C.A., and Hodges J.R. Clinical features of frontal lobe dementia in comparison to Alzheimer's disease. J Neural Transm Suppl 47 (1996) 103-123
146. Miller B.L., Cummings J.L., Villanueva-Meyer J., Boone K., Mehringer C.M., Lesser M., et al. Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology 41 (1991) 1374-1382
147. Gregory C., Lough S., Stone V., Erzinclioglu S., Martin L., Baron-Cohen S., et al. Theory of mind in patients with frontal variant frontotemporal dementia and Alzheimer's disease: theoretical and practical implications. Brain 125 Pt 4 (2002) 752-764
148. Colosimo C., Hughes A.J., Kilford L., and Lees A.J. Lewy body cortical involvement may not always predict dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 74 (2003) 852-856
149. Lezak M.D., Howieson D.B., and Loring D.W. Neuropsychological Assessment (2004), Oxford University Press, New York
150. Morgan C.D., and Baade L.E. Neuropsychological testing and assessment scales for dementia of the Alzheimer's type. Psychiatr Clin North Am 20 (1997) 25-43
151. Sano M. Neuropsychological testing in the diagnosis of dementia. J Geriatr Psychiatry Neurol 19 (2006) 155-159
152. De Vreese L.P., Neri M., Fioravanti M., Belloi L., and Zanetti O. Memory rehabilitation in Alzheimer's disease: a review of progress. Int J Geriatr Psychiatry 16 (2001) 794-809
153. Christensen H., Griffiths K., Mackinnon A., and Jacomb P. A quantitative review of cognitive deficits in depression and Alzheimer-type dementia. J Int Neuropsychol Soc 3 (1997) 631-651
154. Simard M., Van Reekumm R., and Cohen T. A review of the cognitive and behavioral symptoms in dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci 12 (2000) 425-450
155. Kramer J.H., Jurik J., Sha S.J., Rankin K.P., Rosen H.J., Johnson J.K., et al. Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease. Cogn Behav Neurol 16 (2003) 211-218
156. Mathuranath P.S., Nestor P.J., Berrios G.E., Rakowicz W., and Hodges J.R. A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology 55 (2000) 1613-1620
157. Gorno-Tempini M.L., Dronkers N.F., Rankin K.P., Ogar J.M., Phengrasamy L., Rosen H.J., et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 55 (2004) 335-346
158. Hodges J.R., Patterson K., Ward R., Garrard P., Bak T., Perry R., et al. The differentiation of semantic dementia and frontal lobe dementia (temporal and frontal variants of frontotemporal dementia) from early Alzheimer's disease: a comparative neuropsychological study. Neuropsychology 13 (1999) 31-40
159. Sjogren M., Wallin A., and Edman A. Symptomatological characteristics distinguish between frontotemporal dementia and vascular dementia with a dominant frontal lobe syndrome. Int J Geriatr Psychiatry 12 (1997) 656-661
160. Butters N., Wolfe J., Martone M., Granholm E., and Cermak L.S. Memory disorders associated with Huntington's disease: verbal recall, verbal recognition and procedural memory. Neuropsychologia 23 (1985) 729-743